Vaccine production in Africa: will initiatives survive?

Article Sidebar

PDF
Published: May 8, 2023
DOI: https://doi.org/10.7196/SAJBL.2023.v16i1.1040

Main Article Content

A Dhai

Abstract

-

Article Details

How to Cite
Vaccine production in Africa: will initiatives survive?. (2023). South African Journal of Bioethics and Law, 16(1), 2-3. https://doi.org/10.7196/SAJBL.2023.v16i1.1040
Issue
Vol. 16 No. 1 (2023)
Section
Editorial
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The SAJBL is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited. 

Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository. 

 

How to Cite

Vaccine production in Africa: will initiatives survive?. (2023). South African Journal of Bioethics and Law, 16(1), 2-3. https://doi.org/10.7196/SAJBL.2023.v16i1.1040

References

James W, Veller M. South Africa’s short-sighted vaccine manufacture and procurement policy compromises Africa’s development. Daily Maverick, 1 May 2023. https://www.dailymaverick.co.za/article/2023-05-01-sas-short- sighted-vaccine-manufacture-and-procurement-policy-compromises-africas- development (accessed 2 May 2023).

Lamptey E, Senkyire EK, Benita DA, Boakye EO. COVID-19 vaccines development in Africa: A review of current situation and existing challenges of vaccine production. Clin Exp Vaccine Res 2022;11:82-88. https://doi.org/10.7774/cevr.2022.11.1.82

Nweneka CV, Disu T. The future of vaccine manufacturing in Africa. Foresight Africa: Brookings, 14 February 2022.

African Union, Africa Centres for Disease Control. Partnerships for African Vaccine Manufacturing (PAVM) Framework for Action. https://africacdc.org/download/ partnerships-for-african-vaccine-manufacturing-pavm-framework-for-action/ (accessed 16 January 2023).

Erondu N. Now is the moment to launch an African vaccine industry. Chatham House, 2022 Now is the moment to launch an African vaccine industry https:// www.chathamhouse.org/publications/the-world-today/2022-08/now-moment- launch-african-vaccine-industry (accessed 16 January 2023).

Berkley S. Ramping up Africa’s vaccine manufacturing capability is good for everyone. Here’s why. World Economic Forum, 17 October 2022. https://www. weforum.org/agenda/2022/10/ramping-up-africa-s-vaccine-manufacturing- capability-is-good-for-everyone-heres-why/ (accessed 16 January 2023).

Jerving S. New tech hub aims to boost access to mRNA COVID-19 vaccines in Africa. Devex, 2021. https://www.devex.com/news/new-tech-hub-aims-to-boost- access-to-mrna-covid-19-vaccines-in-africa-100193 (accessed 16 January 2023).

Nature Editorial. Africa is bringing vaccine manufacturing home. Nature 2022;602:184. https://doi.org/10.1038/d41586-022-00335-9